U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H20O2.C2H7NO
Molecular Weight 245.3584
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of UNDECYLENIC ACID MONOETHANOLAMINE

SMILES

NCCO.OC(=O)CCCCCCCCC=C

InChI

InChIKey=GPOFRJKTYRFQLJ-UHFFFAOYSA-N
InChI=1S/C11H20O2.C2H7NO/c1-2-3-4-5-6-7-8-9-10-11(12)13;3-1-2-4/h2H,1,3-10H2,(H,12,13);4H,1-3H2

HIDE SMILES / InChI

Molecular Formula C11H20O2
Molecular Weight 184.2753
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C2H7NO
Molecular Weight 61.0831
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including http://www.altmedrev.com/publications/7/1/68.pdf | https://www.ncbi.nlm.nih.gov/pubmed/10991877

Undecylenic acid is unsaturated fatty acid, which naturally occurs in sweat, and is commercially produced by the vacuum distillation of castor bean oil. It is recognized as GRASE by FDA, and is marketed over the counter to treat skin infections and to relieve itching. Undecylenic acid acts by inhibition of morphogenesis from yeast to hyphae forms.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
CRUEX

Approved Use

For the cure of most tinea pedis (athlete's foot) and tinea corporis (ringworm).
Curative
CRUEX

Approved Use

For the cure of most tinea pedis (athlete's foot) and tinea corporis (ringworm).
Primary
Unknown

Approved Use

Unknown
Primary
CRUEX

Approved Use

Itching, burning, redness, irritation, scaling, soreness and discomfort which may accompany these conditions
Doses

Doses

DosePopulationAdverse events​
2.2 g 3 times / day multiple, oral
Dose: 2.2 g, 3 times / day
Route: oral
Route: multiple
Dose: 2.2 g, 3 times / day
Co-administed with::
nicotinic acid(50 mgm. morning and night)
Sources:
unhealthy, 56 years
n = 1
Health Status: unhealthy
Condition: psoriasis
Age Group: 56 years
Sex: M
Population Size: 1
Sources:
Disc. AE: Toxic labyrinthitis...
AEs leading to
discontinuation/dose reduction:
Toxic labyrinthitis (1 patient)
Sources:
1 g 3 times / day multiple, oral
Dose: 1 g, 3 times / day
Route: oral
Route: multiple
Dose: 1 g, 3 times / day
Sources:
unhealthy, 8-14 years
n = 4
Health Status: unhealthy
Condition: psoriasis | NEURODERMATITIS
Age Group: 8-14 years
Population Size: 4
Sources:
10 g 3 times / day multiple, oral
Highest studied dose
Dose: 10 g, 3 times / day
Route: oral
Route: multiple
Dose: 10 g, 3 times / day
Sources:
unhealthy, adult
Health Status: unhealthy
Condition: psoriasis
Age Group: adult
Sources:
2 % 1 times / day multiple, topical
Dose: 2 %, 1 times / day
Route: topical
Route: multiple
Dose: 2 %, 1 times / day
Co-administed with::
zinc undecylenate(0.2)
Sources:
unhealthy
n = 29
Health Status: unhealthy
Condition: TINEA PEDIS
Population Size: 29
Sources:
AEs

AEs

AESignificanceDosePopulation
Toxic labyrinthitis 1 patient
Disc. AE
2.2 g 3 times / day multiple, oral
Dose: 2.2 g, 3 times / day
Route: oral
Route: multiple
Dose: 2.2 g, 3 times / day
Co-administed with::
nicotinic acid(50 mgm. morning and night)
Sources:
unhealthy, 56 years
n = 1
Health Status: unhealthy
Condition: psoriasis
Age Group: 56 years
Sex: M
Population Size: 1
Sources:
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Screening for new compounds with antiherpes activity.
1984 Oct
Cometabolic biosynthesis of copolyesters consisting of 3-hydroxyvalerate and medium-chain-length 3-hydroxyalkanoates by Pseudomonas sp. DSY-82.
2001 Oct
Antioxidant and cyclooxygenase activities of fatty acids found in food.
2002 Apr 10
Mutations in erg4 affect the sensitivity of Saccharomyces cerevisiae to medium-chain fatty acids.
2002 Apr 15
One-pot sequences of reactions with sol-gel entrapped opposing reagents: an enzyme and metal-complex catalysts.
2002 Dec 4
Allergic contact dermatitis from undecylenic acid in a commercial antifungal nail solution.
2002 Feb
Undecylenic acid. Monograph.
2002 Feb
Enzymatic synthesis of hydrophilic undecylenic acid sugar esters and their biodegradability.
2003 Jan
EDC-mediated DNA attachment to nanocrystalline CVD diamond films.
2006 Aug 15
Self-assembled thermo- and pH responsive micelles of poly(10-undecenoic acid-b-N-isopropylacrylamide) for drug delivery.
2006 Dec 1
UV photodissociation spectroscopy of oxidized undecylenic acid films.
2006 Mar 16
Natural treatment of chronic rhinosinusitis.
2006 Sep
Grazing angle mirror-backed reflection (GMBR) for infrared analysis of monolayers on silicon.
2006 Sep 14
Nanovectors for anticancer agents based on superparamagnetic iron oxide nanoparticles.
2007
Mechanisms of thermal decomposition of organic monolayers grafted on (111) silicon.
2007 Jan 30
Self-assembled monolayers with latent aldehydes for protein immobilization.
2007 Jan-Feb
Enzymatic synthesis of arbutin undecylenic acid ester and its inhibitory effect on mushroom tyrosinase.
2007 Mar
Cell adhesion properties on photochemically functionalized diamond.
2007 May 8
Effect of double bonds in the formation of sodium dodecanoate and sodium 10-undecenoate mixed micelles in water.
2007 Oct 11
Effects of insemination quantity on honey bee queen physiology.
2007 Oct 3
Topographical and functional characterization of the ssDNA probe layer generated through EDC-mediated covalent attachment to nanocrystalline diamond using fluorescence microscopy.
2008 Aug 19
A rapid and sensitive screening system for human type I collagen with the aim of discovering potent anti-aging or anti-fibrotic compounds.
2008 Dec 31
Comparison of the skin sensitizing potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the guinea pig maximization test (GPMT).
2008 Jun
Oxidation-triggered release of fluorescent molecules or drugs from mesoporous Si microparticles.
2008 Nov 25
Spectra and kinetic studies of the compound I derivative of cytochrome P450 119.
2008 Oct 8
Polymerizable vesicles based on a single-tailed fatty acid surfactant: a simple route to robust nanocontainers.
2009 Feb 3
The compatibility of hepatocytes with chemically modified porous silicon with reference to in vitro biosensors.
2009 Jan
Porous silicon for photosensitized formation of singlet oxygen in water and in simulated body fluid: two methods of modification by undecylenic acid.
2009 Jun
Fed-batch production of unsaturated medium-chain-length polyhydroxyalkanoates with controlled composition by Pseudomonas putida KT2440.
2009 Mar
Electrochemical behavior of gold colloidal alkyl modified silicon surfaces.
2009 Nov
Capric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion and biofilm formation.
2010 Aug 10
Simple surface modification of poly(dimethylsiloxane) for DNA hybridization.
2010 Dec 6
Bioconjugate functionalization of thermally carbonized porous silicon using a radical coupling reaction.
2010 Dec 7
Rapid approach to biobased telechelics through two one-pot thiol-ene click reactions.
2010 Jun 14
Simultaneous biosynthesis of two copolymers in Pseudomonas putida GPo1 using a two-stage continuous culture system.
2010 Jun 14
Production of functionalized polyhydroxyalkanoates by genetically modified Methylobacterium extorquens strains.
2010 Sep 16
Patents

Sample Use Guides

Undecylenic acid antifungal liquid should be applied to affected area topically.
Route of Administration: Topical
To investigate effect of undecylenic acid on Candida albicans morphogenesis, cells were grown overnight at 30°C on YPD agar and harvested by scraping the cells from the plate and suspending in YPD broth. Two milliliters of cells at 106 cells/ml was distributed into tubes containing liner, approximately 0.5 g of liner per tube. The cultures were incubated at 39°C with agitation for 2 h; planktonic cells were analyzed microscopically to determine the percentage of cells with germ tubes. The presence of Undecylenic acid inhibited the appearance of germ tubes, with 10 μM UDA causing a sevenfold reduction.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:20:39 GMT 2023
Edited
by admin
on Fri Dec 15 15:20:39 GMT 2023
Record UNII
89FB3I7256
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
UNDECYLENIC ACID MONOETHANOLAMINE
Common Name English
MONOETHANOLAMINE UNDECYLENATE
Common Name English
MEA-UNDECYLENATE [INCI]
Common Name English
MEA-UNDECYLENATE
INCI  
INCI  
Official Name English
ETHANOL, 2-AMINO-, 10-UNDECENOATE (SALT)
Systematic Name English
10-UNDECENOIC ACID, COMPD. WITH 2-AMINOETHANOL (1:1)
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID20971980
Created by admin on Fri Dec 15 15:20:39 GMT 2023 , Edited by admin on Fri Dec 15 15:20:39 GMT 2023
PRIMARY
CAS
12041-82-6
Created by admin on Fri Dec 15 15:20:39 GMT 2023 , Edited by admin on Fri Dec 15 15:20:39 GMT 2023
SUPERSEDED
CAS
56532-40-2
Created by admin on Fri Dec 15 15:20:39 GMT 2023 , Edited by admin on Fri Dec 15 15:20:39 GMT 2023
PRIMARY
ECHA (EC/EINECS)
260-247-7
Created by admin on Fri Dec 15 15:20:39 GMT 2023 , Edited by admin on Fri Dec 15 15:20:39 GMT 2023
PRIMARY
PUBCHEM
25494
Created by admin on Fri Dec 15 15:20:39 GMT 2023 , Edited by admin on Fri Dec 15 15:20:39 GMT 2023
PRIMARY
FDA UNII
89FB3I7256
Created by admin on Fri Dec 15 15:20:39 GMT 2023 , Edited by admin on Fri Dec 15 15:20:39 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY